Quote:

---

“ The email he sent to Olive,
Purports to know what could be a viable treatment for Holly knowing nothing of her case specifics and no scientific/ medical training.

“ “Olive—I’m a reporter with STAT, a digital media company that covers health, medicine, and life sciences. I’m interested in speaking with you about Holly Kennedy and her decision to be treated with Leronlimab, despite any clinical evidence of efficacy in treating TNBC. Your posts suggest she’s been helped by Leronlimab, yet she was hospitalized soon after returning to Ireland. It seems like her condition has worsened, not improved. What evidence is there that Leronlimab has helped her? Do you know if Holly has pursued treatment with Trodelvy, for instance, which was recently approved in the US for advanced TNBC? Are you worried at all that you and Holly are being exploited by people promoting Leronlimab and Cytodyn for financial reasons? I’d like to speak with you if you have the time. Thank you—Adam Feurstein.”

Oh and ‘financial reasons’ So Trodelvy is free?? Nader is is the most approachable CEO out there.

He posts his number out there. Takes calls to assist people looking for options. The company has paid travel costs for participants (great distances even) they are still in testing and submitting processes but this a CEO and a company with a heart that DOES ACTUALLY CARE about the patients.
Yeah they will sell if approved, exactly who doesn’t? Exploiting for financial reasons as he says is false argument.

Leash your dog.”

---